VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Ruxolitinib discontinuation syndrome: real-world data

Francesca Palandri, PhD, MD, of the University Hospital, Bologna, Italy, discusses real-world data on the incidence of ruxolitinib discontinuation syndrome in myelofibrosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter